Logo image of ACAD

ACADIA PHARMACEUTICALS INC (ACAD) Stock Analyst Ratings

NASDAQ:ACAD - Nasdaq - US0042251084 - Common Stock - Currency: USD

19.95  -0.34 (-1.68%)

After market: 19.95 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to ACAD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 25.61. This target is 28.36% above the current price.
ACAD was analyzed by 25 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ACAD.
In the previous month the buy percentage consensus was at a similar level.
ACAD was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
ACAD Historical Analyst RatingsACAD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 19.9511.1126.5225.6140.95 - -44.31% 32.93% 28.36% 105.26%
ACAD Current Analyst RatingACAD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-02-11 Deutsche Bank Initiate Hold
2025-01-03 Guggenheim Downgrade Buy -> Neutral
2024-11-07 Needham Reiterate Buy -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Market Perform
2024-08-08 UBS Maintains Buy -> Buy
2024-08-08 Citigroup Maintains Buy -> Buy
2024-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-07 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-08-07 Needham Maintains Buy -> Buy
2024-08-07 RBC Capital Maintains Outperform -> Outperform
2024-08-07 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-07-12 Morgan Stanley Maintains Overweight -> Overweight
2024-06-27 BMO Capital Initiate Outperform
2024-06-25 RBC Capital Reiterate Outperform -> Outperform
2024-05-10 B of A Securities Maintains Neutral -> Neutral
2024-05-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-09 Mizuho Maintains Neutral -> Neutral
2024-05-09 Needham Reiterate Buy -> Buy
2024-05-09 Stifel Maintains Hold -> Hold
2024-05-09 Baird Maintains Outperform -> Outperform
2024-05-09 Citigroup Maintains Buy -> Buy
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-06 Oppenheimer Maintains Perform -> Perform
2024-04-30 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-09 Needham Reiterate Buy -> Buy
2024-03-25 JP Morgan Maintains Overweight -> Overweight
2024-03-13 Morgan Stanley Maintains Overweight -> Overweight
2024-03-12 Cantor Fitzgerald Maintains Overweight -> Overweight